Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Bowel Diseases | 3 | 2023 | 110 | 1.360 |
Why?
|
| Surgical Wound Infection | 2 | 2023 | 124 | 0.820 |
Why?
|
| Pouchitis | 2 | 2022 | 8 | 0.810 |
Why?
|
| Colorectal Surgery | 3 | 2025 | 51 | 0.800 |
Why?
|
| Inpatients | 2 | 2023 | 314 | 0.690 |
Why?
|
| Dietary Supplements | 1 | 2023 | 235 | 0.670 |
Why?
|
| Surgeons | 3 | 2022 | 189 | 0.640 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 20 | 0.620 |
Why?
|
| Postoperative Complications | 5 | 2025 | 1313 | 0.590 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 460 | 0.560 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 286 | 0.510 |
Why?
|
| Colectomy | 4 | 2025 | 122 | 0.470 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 261 | 0.450 |
Why?
|
| Diverticulitis, Colonic | 2 | 2024 | 38 | 0.410 |
Why?
|
| Rectal Neoplasms | 2 | 2025 | 138 | 0.380 |
Why?
|
| Quality Improvement | 2 | 2025 | 459 | 0.360 |
Why?
|
| Internship and Residency | 3 | 2025 | 805 | 0.340 |
Why?
|
| Retrospective Studies | 11 | 2025 | 6830 | 0.280 |
Why?
|
| Humans | 22 | 2025 | 64882 | 0.240 |
Why?
|
| Colostomy | 3 | 2023 | 25 | 0.240 |
Why?
|
| United States | 8 | 2025 | 8071 | 0.230 |
Why?
|
| Correspondence as Topic | 1 | 2025 | 11 | 0.220 |
Why?
|
| Neoadjuvant Therapy | 1 | 2025 | 99 | 0.220 |
Why?
|
| Colonic Pouches | 2 | 2022 | 17 | 0.210 |
Why?
|
| Personnel Selection | 1 | 2025 | 57 | 0.210 |
Why?
|
| Adult | 9 | 2025 | 17286 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 105 | 0.200 |
Why?
|
| Female | 15 | 2025 | 33885 | 0.200 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 76 | 0.200 |
Why?
|
| Intestinal Perforation | 1 | 2023 | 17 | 0.200 |
Why?
|
| Crohn Disease | 2 | 2022 | 107 | 0.190 |
Why?
|
| Diverticulitis | 1 | 2023 | 33 | 0.190 |
Why?
|
| Insurance Coverage | 1 | 2023 | 98 | 0.190 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 126 | 0.190 |
Why?
|
| Male | 15 | 2025 | 30916 | 0.180 |
Why?
|
| Rectal Fistula | 1 | 2022 | 21 | 0.180 |
Why?
|
| Rectal Diseases | 1 | 2022 | 29 | 0.180 |
Why?
|
| Fecal Incontinence | 1 | 2022 | 32 | 0.180 |
Why?
|
| Patient Discharge | 1 | 2025 | 518 | 0.170 |
Why?
|
| Length of Stay | 3 | 2025 | 825 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 150 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2025 | 446 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 220 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2020 | 13 | 0.160 |
Why?
|
| Urinary Diversion | 1 | 2020 | 12 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2023 | 5773 | 0.150 |
Why?
|
| Environment | 1 | 2019 | 124 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2018 | 8 | 0.140 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 12 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 407 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 61 | 0.140 |
Why?
|
| Endarterectomy, Carotid | 1 | 2018 | 79 | 0.140 |
Why?
|
| Tyrosine | 1 | 2018 | 93 | 0.140 |
Why?
|
| beta Catenin | 1 | 2018 | 99 | 0.140 |
Why?
|
| Prognosis | 2 | 2019 | 1774 | 0.140 |
Why?
|
| Laparoscopy | 1 | 2022 | 489 | 0.130 |
Why?
|
| Middle Aged | 10 | 2025 | 18184 | 0.130 |
Why?
|
| Anastomosis, Surgical | 3 | 2023 | 118 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 214 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 671 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 90 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 625 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 147 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 521 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 767 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1556 | 0.110 |
Why?
|
| Elective Surgical Procedures | 2 | 2025 | 119 | 0.100 |
Why?
|
| Mass Screening | 1 | 2020 | 695 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 112 | 0.100 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 97 | 0.100 |
Why?
|
| Mortality | 1 | 2015 | 159 | 0.100 |
Why?
|
| Reoperation | 1 | 2015 | 300 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2025 | 130 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2025 | 540 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 2093 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2017 | 522 | 0.090 |
Why?
|
| Pneumonia | 1 | 2015 | 291 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 918 | 0.090 |
Why?
|
| Risk Factors | 4 | 2025 | 5400 | 0.090 |
Why?
|
| Recurrence | 2 | 2024 | 655 | 0.090 |
Why?
|
| Time Factors | 3 | 2025 | 3752 | 0.090 |
Why?
|
| Aged | 5 | 2025 | 14899 | 0.080 |
Why?
|
| Rectum | 2 | 2023 | 96 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1208 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 2609 | 0.070 |
Why?
|
| Incidence | 2 | 2024 | 1412 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 2481 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2025 | 50 | 0.060 |
Why?
|
| Proprotein Convertases | 1 | 2004 | 4 | 0.050 |
Why?
|
| Serpins | 1 | 2004 | 18 | 0.050 |
Why?
|
| Propensity Score | 1 | 2025 | 189 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2018 | 881 | 0.050 |
Why?
|
| Ileostomy | 1 | 2023 | 28 | 0.050 |
Why?
|
| Sexism | 1 | 2023 | 33 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 37 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 348 | 0.040 |
Why?
|
| Colon | 1 | 2023 | 147 | 0.040 |
Why?
|
| Anal Canal | 1 | 2022 | 38 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 303 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 5595 | 0.040 |
Why?
|
| Drosophila | 1 | 2004 | 480 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 745 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2020 | 16 | 0.040 |
Why?
|
| Medical Illustration | 1 | 2020 | 4 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2020 | 10 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 153 | 0.040 |
Why?
|
| Cystectomy | 1 | 2020 | 35 | 0.040 |
Why?
|
| Operative Time | 1 | 2020 | 92 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2020 | 142 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2020 | 97 | 0.040 |
Why?
|
| Career Choice | 1 | 2020 | 126 | 0.040 |
Why?
|
| Data Warehousing | 1 | 2018 | 7 | 0.040 |
Why?
|
| Massachusetts | 1 | 2025 | 2140 | 0.040 |
Why?
|
| Protective Factors | 1 | 2018 | 33 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 758 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2018 | 125 | 0.030 |
Why?
|
| Health Policy | 1 | 2020 | 190 | 0.030 |
Why?
|
| Public Health | 1 | 2020 | 186 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 426 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 140 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 67 | 0.030 |
Why?
|
| Prednisone | 1 | 2017 | 83 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 325 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 727 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 843 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 960 | 0.030 |
Why?
|
| Health Promotion | 1 | 2020 | 512 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2017 | 189 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1137 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1690 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 368 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1035 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2755 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1099 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 4787 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2656 | 0.020 |
Why?
|
| Molting | 1 | 2004 | 9 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 21276 | 0.010 |
Why?
|
| Furin | 1 | 2004 | 10 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 25 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 213 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 157 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 202 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2004 | 138 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 895 | 0.010 |
Why?
|